Total raised
—
Stage
Pre-Funding
Founded
2012
Headcount
5
HQ
Ramat Gan
Sector
Health Tech & Life Sciences
About
GlucoCheck is developing a proprietary, patent-pending solution for self-monitoring of blood glucose (SMBG). GlucoCheck offers pain-free, alternative-site SMBG designed to meet FDA and medical staff requirements as a permanent replacement for fingertip SMBG.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is GlucoCheck's primary focus?
- GlucoCheck is developing a proprietary, patent-pending solution for pain-free, alternative-site self-monitoring of blood glucose (SMBG).
- When was GlucoCheck founded?
- GlucoCheck was founded in December 2012.
- What is the operational status of GlucoCheck?
- GlucoCheck is currently inactive and ceased to operate in May 2018.
- Where is GlucoCheck's headquarters located?
- GlucoCheck's headquarters is in Ramat Gan, Center District, Israel.
- What is GlucoCheck's current funding stage?
- GlucoCheck is in the Pre-Funding stage, with a total raised amount of $0 USD.
- How many employees did GlucoCheck have?
- GlucoCheck had an estimated 1-10 employees, with an exact count of 5.
- Who is a founder of GlucoCheck?
- Adi Kahn is a founder of GlucoCheck.
- What sector does GlucoCheck primarily operate in?
- GlucoCheck primarily operates in the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Monitors.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Monitors
Target customers
Healthcare & Life SciencesHealthcarePatientsConsumers
Business model
B2C
Highlights
Verified
Tags
real-timepain-freediabetesmedical-devicesmonitoringpatientshome-careadherence